Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own14.93% Shs Outstand18.90M Perf Week-8.32%
Market Cap99.98M Forward P/E- EPS next Y-0.90 Insider Trans0.21% Shs Float16.68M Perf Month21.05%
Income-9.70M PEG- EPS next Q-0.25 Inst Own21.60% Short Float4.39% Perf Quarter47.77%
Sales0.30M P/S333.27 EPS this Y21.30% Inst Trans-11.97% Short Ratio4.73 Perf Half Y-14.68%
Book/sh0.92 P/B5.75 EPS next Y-21.60% ROA-33.10% Target Price9.00 Perf Year-26.43%
Cash/sh1.84 P/C2.88 EPS next 5Y- ROE-50.70% 52W Range2.97 - 8.50 Perf YTD-7.84%
Dividend- P/FCF- EPS past 5Y0.00% ROI-50.70% 52W High-37.65% Beta-0.58
Dividend %- Quick Ratio17.50 Sales past 5Y- Gross Margin- 52W Low78.45% ATR0.45
Employees25 Current Ratio17.50 Sales Q/Q13.50% Oper. Margin- RSI (14)54.45 Volatility5.50% 9.76%
OptionableYes Debt/Eq0.85 EPS Q/Q82.40% Profit Margin- Rel Volume0.54 Prev Close5.29
ShortableYes LT Debt/Eq0.85 EarningsAug 07 AMC Payout- Avg Volume154.55K Price5.30
Recom2.00 SMA20-2.19% SMA5026.93% SMA2007.65% Volume28,494 Change0.19%
10-Jul-14Initiated Maxim Group Buy $10
13-Nov-13Reiterated Aegis Capital Buy $14 → $10
01-Oct-13Reiterated Aegis Capital Buy $14
16-Jul-13Initiated Cantor Fitzgerald Buy $10
01-Apr-13Reiterated Aegis Capital Buy $12 → $14
12-Dec-12Initiated Aegis Capital Buy $12
18-Sep-14 04:00PM  TROVAGENE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
17-Sep-14 08:05AM  Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
15-Sep-14 07:50AM  Can The Uptrend Continue for TrovaGene (TROV)? Zacks
08-Sep-14 06:49AM  Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? Zacks
04-Sep-14 06:59AM  How TrovaGene (TROV) Stock Stands Out in a Strong Industry Zacks
26-Aug-14 08:24AM  Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics PR Newswire
07:07AM  TrovaGene (TROV) Jumps: Stock Rises 9.2% Zacks
25-Aug-14 08:05AM  Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. PR Newswire +9.18%
22-Aug-14 07:33AM  Can the Rally in TrovaGene (TROV) Shares Continue? Zacks
20-Aug-14 04:47PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:05AM  Trovagene Provides Update on Its Urine-Based HPV Test PR Newswire
19-Aug-14 01:04PM  TROVAGENE, INC. Financials EDGAR Online Financials
18-Aug-14 07:00AM  TrovaGene (TROV) Worth Watching: Stock Rises 8.8% Zacks +23.33%
12-Aug-14 09:53AM  TrovaGene (TROV) Sees Hammer Chart Pattern: Time to Buy? Zacks +5.20%
08:05AM  Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
08-Aug-14 06:01AM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07-Aug-14 04:05PM  Trovagene, Inc. Announces Second Quarter 2014 Financial Results PR Newswire
04:01PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q2 2014 Trovagene Inc Earnings Release - 4:00 pm ET CCBN
30-Jul-14 08:05AM  Trovagene Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call PR Newswire +5.63%
10-Jul-14 06:09AM  Coverage initiated on TrovaGene by Maxim Group Briefing.com
01-Jul-14 04:27PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga EDGAR Online
08:05AM  Trovagene Secures $15 Million in Debt Financing From Silicon Valley Bank and Oxford Finance PR Newswire
30-Jun-14 08:07AM  Trovagene enters into strategic alliance with Lurie Cancer Center, NMDTI theflyonthewall.com
08:05AM  Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute PR Newswire
16-Jun-14 08:07AM  Trovagene announces clinical collaboratoin with Dana-Farber Cancer Institute at theflyonthewall.com
08:07AM  Trovagene announces clinical collaboratoin with Dana-Farber Cancer Institute
08:00AM  Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute PR Newswire
08:00AM  Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute
02-Jun-14 04:43PM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online +8.73%
04:43PM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
12:45PM  Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response PR Newswire
12:45PM  Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response
28-May-14 04:05PM  Trovagene to Present at Jefferies 2014 Global Healthcare Conference PR Newswire
04:05PM  Trovagene to Present at Jefferies 2014 Global Healthcare Conference
12:24PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
12:24PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:00AM  Trovagene's Precision Cancer Monitoring Technology Referenced in Multi-Disciplinary Clinical Consensus Guidelines PR Newswire
09:00AM  Trovagene's Precision Cancer Monitoring Technology Referenced in Multi-Disciplinary Clinical Consensus Guidelines
21-May-14 06:44AM  Ophthotech (OPHT) Jumps: Stock Rises 24.5% Zacks
06:44AM  Ophthotech (OPHT) Jumps: Stock Rises 24.5%
20-May-14 01:04PM  TROVAGENE, INC. Financials EDGAR Online Financials
01:04PM  TROVAGENE, INC. Financials
11:05AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
11:05AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:24AM  TrovaGene (TROV) is Oversold: Can It Recover? Zacks
09:00AM  Trovagene Announces Publication of Data from Clinical Validation Program Using Its Precision Cancer Monitoring Platform PR Newswire
14-May-14 05:00PM  Trovagene Announces Data Presentations, Published Abstracts at Annual Meeting of American Society of Clinical Oncology PR Newswire -9.27%
13-May-14 06:01AM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
12-May-14 08:12PM  TrovaGene's (TROV) CEO Antonius Schuh on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:08PM  Trovagene reports Q1 EPS (17c), consensus (20c) at theflyonthewall.com
04:06PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Trovagene, Inc. Announces First Quarter 2014 Financial Results PR Newswire
07:07AM  Q1 2014 TrovaGene Inc Earnings Release - 4:00 pm ET CCBN
09-May-14 06:36AM  Chelsea Therapeutics International Ltd. (CHTP) Looks Strong as Stock Shoots up 31.6% Zacks
05-May-14 04:00PM  Trovagene Schedules Release of First Quarter 2014 Financial Results and Investor Conference Call PR Newswire
06:32AM  Sequenom Inc. (SQNM) in Focus: Stock Rallies 8.6% Zacks
02-May-14 06:43AM  Merrimack Pharmaceuticals, Inc. (MACK) Appears Robust as Stock Shoots up 59.2% Zacks
01-May-14 06:40AM  Strength Seen in Avanir Pharmaceuticals, Inc. (AVNR) as Stock Shoots up 45.6% Zacks
29-Apr-14 05:33AM  Strength Seen in Agenus Inc. (AGEN) as Stock Shoots Up 19.5% Zacks +15.69%
28-Apr-14 02:03AM  Tenet Healthcare (THC) Jumps: Stock Up 9.1% Zacks
02:00AM  Universal Health Services (UHS) Jumps: Stock Up 6.1% Zacks
22-Apr-14 01:52AM  Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% Zacks
17-Apr-14 06:02PM  Nasdaq stocks posting largest percentage increases AP
16-Apr-14 06:03PM  Nasdaq stocks posting largest percentage increases AP +12.08%
10:47AM  TrovaGene (TROV) Enters Oversold Territory Zacks
14-Apr-14 10:18AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -6.98%
08-Apr-14 04:03PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
11:08AM  Trovagene says diagnostic platform demonstrates ability to monitor mutations at theflyonthewall.com
11:00AM  Clinical Data Presented at AACR Demonstrate Ability of Trovagene's Molecular Diagnostic Platform to Non-Invasively Track Cancer Patients' Response to Therapy PR Newswire
01-Apr-14 08:00AM  Trovagene Announces Clinical Data Presentation for Its Oncogene Mutation Monitoring Platform at the American Association for Cancer Research Annual Meeting PR Newswire
31-Mar-14 06:54AM  Weakness Seen in MannKind (MNKD): Stock Falls 7.1% Zacks +5.91%
26-Mar-14 08:00AM  Genomics and Molecular Diagnostics Pioneer Charles Cantor, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
21-Mar-14 01:04PM  TROVAGENE, INC. Financials EDGAR Online Financials
19-Mar-14 08:00AM  Trovagene and Catholic Health Initiatives Center for Translational Research Partner to Clinically Evaluate Non-Invasive Genomic Diagnostics to Improve Cancer Care PR Newswire
17-Mar-14 10:05PM  TrovaGene's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha +6.53%
04:11PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements EDGAR Online
04:01PM  TROVAGENE, INC. Files SEC form 10-K, Annual Report EDGAR Online
04:00PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire
08:00AM  Trovagene Releases Its First Oncogene Mutation Assay Using Next Generation Sequencing, Expands Its Non-Invasive Cancer Monitoring Platform PR Newswire
03-Mar-14 08:00AM  Trovagene Schedules Release of Fourth Quarter and Year End 2013 Financial Results and Investor Conference Call PR Newswire
19-Feb-14 08:10AM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
08:00AM  Dr. Rodney S. Markin Joins Trovagene's Board of Directors PR Newswire
11-Feb-14 06:02AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
06-Feb-14 08:00AM  Trovagene to Present at Two Upcoming Investor Conferences PR Newswire
05-Feb-14 11:40AM  Myriad Genetics rallies after buying rival, increasing 2014 outlook at theflyonthewall.com
11:40AM  Myriad Genetics rallies after buying rival, increasing 2014 outlook
21-Jan-14 07:04AM  Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO at Seeking Alpha
07:04AM  Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO
13-Jan-14 09:13AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
09:13AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure
06-Jan-14 09:18AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:18AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:00AM  Trovagene and US Oncology Research Collaborate on a Prospective Study for Urine-based KRAS Testing in Patients with Metastatic Pancreatic Cancer PR Newswire
05:00AM  Trovagene and US Oncology Research Collaborate on a Prospective Study for Urine-based KRAS Testing in Patients with Metastatic Pancreatic Cancer
30-Dec-13 04:21PM  Trovagene: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
04:21PM  Trovagene: Strong Biotech 'January Effect' Candidate For 2014
27-Dec-13 05:59PM  Nasdaq stocks posting largest percentage increases AP +5.94%
01:28PM  Nasdaq stocks posting largest percentage increases AP
26-Dec-13 05:54PM  Nasdaq stocks posting largest percentage increases AP +5.30%
Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. Its technology is used in the detection and monitoring of diseases in various medical disciplines, primarily the management of cancer treatment. The company's proprietary urine-based molecular diagnostic tests are used to detect cell-free DNA and RNA originating from normal and diseased cell death that can be isolated and detected from urine. Its technology is applied in various testing, such as tumor mutation detection and monitoring, infectious disease monitoring, transplantation monitoring, and prenatal genetic diagnostics. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZANIBONI STEVECFOJun 09Buy3.956,32925,0006,329Jun 10 03:59 PM